practical considerations for subcutaneous rituximab
Published 6 years ago • 1.3K plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
2:25
subcutaneous rituximab: a new approach to treating fl
-
0:52
dr. ansell on fda approval of subcutaneous rituximab in select blood cancers
-
1:20
simon rule, md: the impact of subcutaneous rituximab on clinical practice
-
0:48
martin barrett on intravenous versus subcutaneous rituximab
-
58:11
follicular lymphoma: changes in the treatment landscape
-
3:58
subcutaneous rituximab versus intravenous rituximab – safety and efficacy results
-
4:37
intravenous or subcutaenous rituximab for fl in the sabrina study
-
9:22
follicular lymphoma: novel approaches with rituximab
-
6:47
using rituximab in non-hodgkin lymphoma
-
5:12
follicular lymphoma: overview of treatment options
-
2:11
dr. lyman on rituximab biosimilars in non-hodgkin lymphoma
-
1:33
sabrina trial: subcutaneous versus intravenous rituximab for follicular lymphoma
-
2:51
mabcute study: extended maintenance with subcutaneous rituximab vs observation in inhl
-
2:03
dr. lugtenburg on maintenance rituximab in dlbcl
-
3:41
comorbidities and rituximab-based therapy in fl
-
4:07
rituximab, obinutuzumab, and ofatumumab in cll
-
1:55
ibrutinib in combination with rituximab – the future of treating fl
-
6:53
immunosuppressive therapy in itp
-
3:33
nhl studies: car t therapy, rituximab maintenance, & pd-l1